402 related articles for article (PubMed ID: 7513611)
1. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of commitment by K562 human erythroleukemia cells.
Rowley PT; Ohlsson-Wilhelm BM
Prog Clin Biol Res; 1985; 191():217-31. PubMed ID: 3863148
[TBL] [Abstract][Full Text] [Related]
3. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
[TBL] [Abstract][Full Text] [Related]
4. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation.
Friend C; Zajac-Kaye M; Holland JG; Pogo BG
Cancer Res; 1987 Jan; 47(2):378-82. PubMed ID: 3466690
[TBL] [Abstract][Full Text] [Related]
5. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
Honma Y; Onozuka Y; Okabe-Kado J; Kasukabe T; Hozumi M
Cancer Res; 1991 Sep; 51(17):4535-8. PubMed ID: 1873797
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a K562 cell line resistant to 1-beta-D-arabinofuranosylcytosine-mediated erythroid induction.
Biancha Scarrà G; Fiorentini P; Gambari R; Nastruzzi C; Barbieri R; Sessarego M; Ravazzolo R; Garrè C
Exp Hematol; 1989 Sep; 17(8):859-64. PubMed ID: 2475359
[TBL] [Abstract][Full Text] [Related]
7. K562 erythroleukemia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation.
Järvinen M; Andersson LC; Virtanen I
J Cell Physiol; 1990 May; 143(2):310-20. PubMed ID: 1692028
[TBL] [Abstract][Full Text] [Related]
8. ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.
Woessmann W; Zwanzger D; Borkhardt A
Cell Biol Int; 2004; 28(5):403-10. PubMed ID: 15193284
[TBL] [Abstract][Full Text] [Related]
9. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease.
Bianchi Scarrà GL; Romani M; Coviello DA; Garrè C; Ravazzolo R; Vidali G; Ajmar F
Cancer Res; 1986 Dec; 46(12 Pt 1):6327-32. PubMed ID: 3536078
[TBL] [Abstract][Full Text] [Related]
10. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452
[TBL] [Abstract][Full Text] [Related]
11. Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis.
Kawasaki N; Morimoto K; Tanimoto T; Hayakawa T
Arch Biochem Biophys; 1996 Apr; 328(2):289-94. PubMed ID: 8645006
[TBL] [Abstract][Full Text] [Related]
12. Relationship between a tumor promoter-induced decrease in queuine modification of transfer RNA in normal human cells and the expression of an altered cell phenotype.
Elliott MS; Katze JR; Trewyn RW
Cancer Res; 1984 Aug; 44(8):3215-9. PubMed ID: 6589040
[TBL] [Abstract][Full Text] [Related]
13. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
Watanabe T; Mitchell T; Sariban E; Sabbath K; Griffin J; Kufe D
Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
[TBL] [Abstract][Full Text] [Related]
14. The role of queuine in the aminoacylation of mammalian aspartate transfer RNAs.
Singhal RP; Vakharia VN
Nucleic Acids Res; 1983 Jun; 11(12):4257-72. PubMed ID: 6553233
[TBL] [Abstract][Full Text] [Related]
15. Queuosine modification of tRNA: its divergent role in cellular machinery.
Vinayak M; Pathak C
Biosci Rep; 2009 Nov; 30(2):135-48. PubMed ID: 19925456
[TBL] [Abstract][Full Text] [Related]
16. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Tsuruo T
Cancer Res; 1991 May; 51(10):2582-6. PubMed ID: 1673636
[TBL] [Abstract][Full Text] [Related]
18. Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: dependency on the inducing agent.
Nathan I; Ben-Valid I; Henzel R; Masalha H; Baram SN; Dvilansky A; Parola AH
Exp Cell Res; 1998 Mar; 239(2):442-6. PubMed ID: 9521862
[TBL] [Abstract][Full Text] [Related]
19. Effect of second-messenger modulators in K-562 cell differentiation: dual action of calcium/phospholipid-dependent protein kinase in the process of differentiation.
Yumoto Y; Tashima M; Kato Y; Ueda T; Okuda T; Ogawa K; Sawada H
J Cell Physiol; 1990 May; 143(2):243-50. PubMed ID: 2159013
[TBL] [Abstract][Full Text] [Related]
20. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
